Variational AI
  • Our Approach
  • Company
  • Team
  • Jobs
  • What’s New
  • Blog
  • Contact
  • Read more: Variational AI announces generative AI project with Merck
    Press Release

    Variational AI announces generative AI project with Merck

    Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.

    Handol Kim Avatar

    Handol Kim

    January 25, 2024
  • Read more: Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AI
    Press Release

    Variational AI Files Two US Provisional Patents for Potential COVID-19 Drug Created by Generative AI

    Variational AI, developer of the Enki™ generative artificial intelligence (AI) drug discovery platform to redefine the economics of drug development, today announced that the company has filed two provisional patents with the United States Patent and Trademark Office

    Jordan Bouclin Avatar

    Jordan Bouclin

    January 5, 2023
  • Read more: Variational AI Adds Jennifer Hamilton as Advisor
    Press Release

    Variational AI Adds Jennifer Hamilton as Advisor

    Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leader Jennifer Hamilton, Ph.D. as a company advisor.

    Jordan Bouclin Avatar

    Jordan Bouclin

    October 26, 2022
  • Read more: Variational AI Adds Leading Oncology Researchers to Scientific Advisory Board
    Press Release

    Variational AI Adds Leading Oncology Researchers to Scientific Advisory Board

    Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and scientific leaders Dr. John F. Boylan and Dr. Mads Daugaard to the company’s Scientific Advisory Board.

    Jordan Bouclin Avatar

    Jordan Bouclin

    June 27, 2022
  • Read more: Variational AI Makes Prestigious Additions to Scientific Advisory Board
    Press Release

    Variational AI Makes Prestigious Additions to Scientific Advisory Board

    Variational AI, developer of state-of-the-art generative AI technology to redefine the economics of drug development by accelerating the discovery of novel and optimized small molecule therapeutics, today announced that it has added industry leaders Alexander Tropsha, Ph.D. and Robert N. Young, Ph.D. to the company’s Scientific Advisory Board.

    Handol Kim Avatar

    Handol Kim

    April 5, 2022
←Previous Page
1 2 3
Next Page→

Our Approach

Company

Our Team

What’s New

Blog

Jobs

Contact

Follow Us

  • LinkedIn
  • X

1825 Quebec Street, #201 Vancouver, BC V5T 2Z3 Canada

+1 604 708 3307

info@variational.ai

© Variational AI Inc.

Terms  |  Privacy Policy